BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12661464)

  • 1. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia].
    Gielen-Wijffels SE; van Mook WN; Ramsay G
    Ned Tijdschr Geneeskd; 2003 Mar; 147(9):419. PubMed ID: 12661464
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of recombinant FVIIa as treatment for abdominal bleeding in acquired hemophilia.
    Makris M; Hampton KK; Preston EE
    Am J Hematol; 2001 Jan; 66(1):67-8. PubMed ID: 11426500
    [No Abstract]   [Full Text] [Related]  

  • 3. [Activated recombinant factor VII for bleeding after a kidney transplant: reflections].
    Pajares A; Larrea L
    Rev Esp Anestesiol Reanim; 2006 Apr; 53(4):266-7; author reply 268. PubMed ID: 16711505
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia].
    Levi M; Friederich PW; van der Meer J
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2534-7. PubMed ID: 12532665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
    Daniloś J; Goral A; Paluszkiewicz P; Przesmycki K; Kotarski J
    Obstet Gynecol; 2003 Jun; 101(6):1172-3. PubMed ID: 12798520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caution with the use of recombinant activated factor VII in treating postoperative hemorrhage in cardiac surgery.
    Al-Ruzzeh S; Mahmoud A; Shah S; O'Regan D
    Ann Thorac Surg; 2007 Jan; 83(1):355; author reply 355-6. PubMed ID: 17184710
    [No Abstract]   [Full Text] [Related]  

  • 7. Thromboelastometry to guide recombinant activated factor VII therapy for postoperative refractory intracranial bleeding.
    Hirasaki Y; Suematsu Y; Yasuda T; Tajima K
    Anesth Analg; 2010 Jan; 110(1):261-2. PubMed ID: 20023190
    [No Abstract]   [Full Text] [Related]  

  • 8. [Application of recombinant activated factor VII in gynecological intervention (case report)].
    Nacheva A; Gateva Zh; Atanasova V
    Akush Ginekol (Sofiia); 2004; 43 Suppl 4():3-5. PubMed ID: 15673003
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of recombinant-activated factor VII to successfully control postoperative critical bleeding after emergency repair of ruptured abdominal aortic aneurysm in a noncoagulopathic patient.
    Dell'Utri D; Passariello M
    J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):570-2. PubMed ID: 16884992
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant activated factor VII in the management of massive obstetric bleeding.
    Palomino MA; Chaparro MJ; de Elvira MJ; Curiel EB
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):226-7. PubMed ID: 16575264
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant activated factor VII for intractable bleeding post splenectomy in a patient with myeloproliferative disorder.
    El Kinge AR; Mahfouz RA; Shamseddine AI; Taher AT
    Blood Coagul Fibrinolysis; 2007 Sep; 18(6):577-9. PubMed ID: 17762536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful control of severe postoperative bleeding with recombinant factor VIIa in a case of refractory idiopathic thrombocytopenic purpura.
    Aguilar C; Lucía JF
    Am J Hematol; 2007 Mar; 82(3):246-7. PubMed ID: 16924645
    [No Abstract]   [Full Text] [Related]  

  • 13. Continuous infusion of recombinant factor VIIa: continue or not?
    Ewenstein BM
    Thromb Haemost; 2001 Oct; 86(4):942-4. PubMed ID: 11686349
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical significance of coagulation studies in predicting response to activated recombinant Factor VII in cardiac surgery patients.
    Lee AI; Campigotto F; Rawn JD; Neuberg D; Kaufman RM; Berliner N
    Br J Haematol; 2012 May; 157(3):397-400. PubMed ID: 22224596
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant activated factor VII.
    Chin C
    Paediatr Anaesth; 2006 Sep; 16(9):907-9. PubMed ID: 16918650
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant activated factor VII in cardiac surgery--will we ever know for sure?
    Silver DA; D'Ambra MN
    Crit Care Med; 2007 Jul; 35(7):1782-3. PubMed ID: 17581365
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
    Jirapinyo M; Manonai J; Herabutya Y; Chuncharunee S
    J Med Assoc Thai; 2007 May; 90(5):977-81. PubMed ID: 17596055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage.
    Franchini M; Lippi G; Franchi M
    BJOG; 2007 Jan; 114(1):8-15. PubMed ID: 17233855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors.
    Giangrande PL; Wilde JT; Madan B; Ludlam CA; Tuddenham EG; Goddard NJ; Dolan G; Ingerslev J
    Haemophilia; 2009 Mar; 15(2):501-8. PubMed ID: 19187194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
    Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.